Molly S Daniels

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist
    Molly S Daniels
    Department of Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Electronic address
    Gynecol Oncol 131:619-23. 2013
  2. doi request reprint A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges
    Molly S Daniels
    U T M D Anderson Cancer Center, Department of Gynecologic Oncology, Unit 1362, PO Box 301439, Houston, TX 77230 1439, USA
    Fam Cancer 10:193-7. 2011
  3. doi request reprint Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer
    Molly S Daniels
    Anderson Cancer Center, Department of Gynecologic Oncology, Unit 1362, PO Box 301439, Houston, TX 77230 1439, USA
    Genet Med 11:624-8. 2009
  4. ncbi request reprint Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer
    Karen H Lu
    Department of Gynecologic Oncology, Division of Surgery, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler, Unit 1362, Houston, TX 77030 4009, USA
    J Clin Oncol 25:5158-64. 2007
  5. doi request reprint Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma
    Shannon N Westin
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 117:2659-67. 2011
  6. ncbi request reprint Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    N Engl J Med 354:261-9. 2006
  7. doi request reprint Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities
    Larissa A Meyer
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Obstet Gynecol 115:945-52. 2010
  8. ncbi request reprint Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Pamela T Soliman
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 23:9344-50. 2005
  9. doi request reprint Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?
    Marisa A Vineyard
    University of Texas Health Science Center, Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA
    Gynecol Oncol 120:229-32. 2011
  10. doi request reprint Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Obstet Gynecol 115:432-4. 2010

Collaborators

Detail Information

Publications19

  1. doi request reprint Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist
    Molly S Daniels
    Department of Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Electronic address
    Gynecol Oncol 131:619-23. 2013
    ....
  2. doi request reprint A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges
    Molly S Daniels
    U T M D Anderson Cancer Center, Department of Gynecologic Oncology, Unit 1362, PO Box 301439, Houston, TX 77230 1439, USA
    Fam Cancer 10:193-7. 2011
    ..Further attention and research should be directed towards provision of genetic counseling and testing during end of life care...
  3. doi request reprint Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer
    Molly S Daniels
    Anderson Cancer Center, Department of Gynecologic Oncology, Unit 1362, PO Box 301439, Houston, TX 77230 1439, USA
    Genet Med 11:624-8. 2009
    ..To determine when, in reference to the course of their treatment, women with ovarian cancer are seen for genetic counseling, as well as to determine what factors influence this timing...
  4. ncbi request reprint Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer
    Karen H Lu
    Department of Gynecologic Oncology, Division of Surgery, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler, Unit 1362, Houston, TX 77030 4009, USA
    J Clin Oncol 25:5158-64. 2007
    ..The purpose of this study was to determine the prevalence of MLH1, MSH2, and MSH6 mutations in an unselected cohort of women diagnosed with endometrial cancer at age younger than 50 years...
  5. doi request reprint Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma
    Shannon N Westin
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 117:2659-67. 2011
    ..Little is known regarding patient satisfaction levels with risk-reduction strategies. Thus, the authors sought to determine levels of patient satisfaction with PS versus RRSO and to identify factors that may influence satisfaction...
  6. ncbi request reprint Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    N Engl J Med 354:261-9. 2006
    ..We designed this study to determine the reduction in the risk of gynecologic cancers associated with prophylactic hysterectomy and bilateral salpingo-oophorectomy in women with the Lynch syndrome...
  7. doi request reprint Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities
    Larissa A Meyer
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Obstet Gynecol 115:945-52. 2010
    ..To estimate the incidence of genetic counseling referral for ovarian cancer patients who are at substantial risk for a BRCA1 or BRCA2 mutation...
  8. ncbi request reprint Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Pamela T Soliman
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 23:9344-50. 2005
    ..The purpose of our study was to determine the likelihood of MMR defects (MSH2, MSH6, MLH1) in women with synchronous endometrial and ovarian cancer...
  9. doi request reprint Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?
    Marisa A Vineyard
    University of Texas Health Science Center, Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA
    Gynecol Oncol 120:229-32. 2011
    ....
  10. doi request reprint Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Obstet Gynecol 115:432-4. 2010
    ..We describe two cases of primary peritoneal cancer after BSO in women with Lynch syndrome or HNPCC...
  11. ncbi request reprint Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations
    Kathleen M Schmeler
    Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA
    Obstet Gynecol 108:515-20. 2006
    ..The objective of this study was to evaluate clinical factors associated with choosing prophylactic bilateral salpingo-oophorectomy (BSO) over surveillance in women with a BRCA1 or BRCA2 mutation...
  12. pmc Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis
    Melinda S Yates
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA
    Cancer Prev Res (Phila) 4:463-70. 2011
    ..We present an updated model for BRCA1/2 mutation-associated ovarian and fallopian tube carcinogenesis, which may aid in identifying improved prevention strategies for high-risk women who delay or decline RRSO...
  13. doi request reprint Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome
    Kaylene J Ready
    Department of Breast Medical Oncology Unit 1354, The University of Texas MD Anderson Cancer Center, PO Box 301439, Houston, TX 77230 1439, USA
    J Cancer Educ 25:401-4. 2010
    ..Cancer genetics education programs should place more emphasis on the areas in which residents' appeared to be deficient in order to aid future physicians in the identification of high-risk individuals...
  14. doi request reprint Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome
    Janice S Kwon
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Cancer 113:326-35. 2008
    ..Screening and prophylactic surgery have been recommended as prevention strategies. In this study, the authors estimated the net health benefits and cost-effectiveness of these strategies in a Markov decision-analytic model...
  15. doi request reprint Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Obstet Gynecol 114:477-9. 2009
    ..Cowden syndrome is an autosomal dominant disorder characterized by the development of multiple intestinal hamartomas, distinctive mucocutaneous lesions, and an increased risk of endometrial, breast, and thyroid cancer...
  16. pmc Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome
    Karen H Lu
    Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Cancer Prev Res (Phila) 6:774-81. 2013
    ..These results show that women with Lynch syndrome do show an endometrial response to short-term exogenous progestins, suggesting that OCP and depo-MPA may be reasonable chemopreventive agents in this high-risk patient population...
  17. pmc What women with ovarian cancer think and know about genetic testing
    Robin A Lacour
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 3721, USA
    Gynecol Oncol 111:132-6. 2008
    ..With the prospect of BRCA-directed therapeutics, we investigated ovarian cancer patients' knowledge and willingness to undergo genetic testing...
  18. doi request reprint Genetic testing by cancer site: uterus
    Molly S Daniels
    Clinical Cancer Genetics Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Cancer J 18:338-42. 2012
    ..HLRCC (hereditary leiomyomatosis and renal cell carcinoma), which has an associated high risk of symptomatic uterine leiomyomas, is reviewed...
  19. ncbi request reprint Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma
    Russell R Broaddus
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:87-94. 2006
    ..It was the purpose of this study to pathologically characterize a series of HNPCC associated endometrial carcinomas...